These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

380 related items for PubMed ID: 32013892

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
    Wu C, Alotaibi GS, Alsaleh K, Sean McMurtry M.
    Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
    [Abstract] [Full Text] [Related]

  • 3. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE, Cavallazzi R.
    PLoS One; 2015 Sep; 10(11):e0143252. PubMed ID: 26587983
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Risk of recurrent venous thromboembolism after discontinuation of vitamin K antagonist treatment: a nested case-control study.
    Martinez C, Katholing A, Folkerts K, Cohen AT.
    J Thromb Haemost; 2016 Jul; 14(7):1374-83. PubMed ID: 27079164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A, Robert-Ebadi H, Combescure C, Grosgurin O, Stirnemann J, Addeo A, Garin N, Agoritsas T, Reny JL, Marti C.
    PLoS One; 2019 Jul; 14(3):e0213940. PubMed ID: 30897142
    [Abstract] [Full Text] [Related]

  • 12. Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: A systematic review and meta-analysis.
    Alhousani M, Malik SU, Abu-Hashyeh A, Poznanski NJ, Al-Hasan S, Roth DF, Alsharedi M, Mustafa B.
    Thromb Res; 2021 Feb; 198():103-114. PubMed ID: 33310644
    [Abstract] [Full Text] [Related]

  • 13. Anticoagulation for the long term treatment of venous thromboembolism in patients with cancer.
    Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ.
    Cochrane Database Syst Rev; 2008 Apr 16; (2):CD006650. PubMed ID: 18425959
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
    Gómez-Outes A, Lecumberri R, Suárez-Gea ML, Terleira-Fernández AI, Monreal M, Vargas-Castrillón E.
    J Cardiovasc Pharmacol Ther; 2015 Sep 16; 20(5):490-500. PubMed ID: 25802423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Decreased Bleeding Incidence with Direct Oral Anticoagulants Compared to Vitamin K Antagonist and Low-Molecular-Weight Heparin in Patients with Sickle Cell Disease and Venous Thromboembolism.
    Patel A, Williams H, Baer MR, Zimrin AB, Law JY.
    Acta Haematol; 2019 Sep 16; 142(4):233-238. PubMed ID: 31108496
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.